BSX
Boston Scientific Corporation
NYQ
$47.68
-0.30
(-0.63%)
Deep pullback · -3.10σ
Hot zone
Grade C
Quarterly financials
last 7 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $5.20B | $3.61B | $1.07B | $1.34B | $171.0M | 69.4% | 20.6% | 25.8% |
| 2025-12-31 | $5.29B | $3.68B | $1.04B | $672.0M | $939.0M | 69.6% | 19.7% | 12.7% |
| 2025-09-30 | $5.07B | $3.54B | $1.05B | $755.0M | $1.09B | 69.9% | 20.7% | 14.9% |
| 2025-06-30 | $5.06B | $3.42B | $943.0M | $797.0M | $1.10B | 67.7% | 18.6% | 15.7% |
| 2025-03-31 | $4.66B | $3.21B | $937.0M | $674.0M | $277.0M | 68.8% | 20.1% | 14.5% |
| 2024-12-31 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |
| 2024-09-30 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |